Search
for
Sort by
Research 31–60 of 233
- Sheehan Syndrome Leading to Acute Systolic and Diastolic Heart Failure: A Case Report
- Netherton Syndrome
- 1249
- Reporting on Adverse Clinical Events
- 446 Protective effect of DA-9401 in finasteride-induced apoptosis in rat testis: inositol requiring kinase 1 and c-Jun N-terminal kinase pathway
- Chemotherapy‐induced alopecia – the urgent need for treatment options
- Alopecia in Association with Malignancy: A Review
- Adverse cutaneous reactions to chemotherapeutic agents and cytokine therapy
- Trichothiodystrophy with Dysmyelination and Central Osteosclerosis
- Parathyroid hormone linked to a collagen binding domain promotes hair growth in a mouse model of chemotherapy-induced alopecia in a dose-dependent manner
- Is there a role for dermatologists in eating disorders?
- Human placenta induces hair regrowth in chemotherapy-induced alopecia via inhibition of apoptotic factors and proliferation of hair follicles
- Zinc Spray for Treatment of Acrodermatitis Enteropathica: A Case Report
- Low Free Thyroxine (FT4) in critically ill juvenile systemic lupus erythematosus: a diagnostic approach
- Mixed “Antiandrogenic” Chemicals at Low Individual Doses Produce Reproductive Tract Malformations in the Male Rat
- Multidimensional assessment of adverse events of finasteride：a real-world pharmacovigilance analysis based on FDA Adverse Event Reporting System (FAERS) from 2004 to April 2024
- Novel Insights into Androgen Hormone Dynamics and Semen Quality Response to Herbal Feed Supplementation in Breeding Bulls
- Anatomy and Physiology of the Skin
- Cutaneous complications of chemotherapeutic agents
- Biocompatible nanoparticles and vesicular systems in transdermal drug delivery for various skin diseases
- Drug-Induced Hair Loss and Hair Growth
- Historical and Current Adenosine Receptor Agonists in Preclinical and Clinical Development
- Severe Acute Respiratory Syndrome Among Children
- Protection Against Chemotherapy-Induced Alopecia
- Management of congenital ichthyoses: European guidelines of care, part two
- THE DISEASE SPECTRUM, EPIDEMIOLOGY, AND ETIOLOGY OF TOXIC-SHOCK SYNDROME
- Anagen effluvium
- Oral Manifestations of Hematologic and Nutritional Diseases
- Cutaneous Manifestations of Eating Disorders
- Chemotherapy-induced alopecia